查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1189853

动脉切开术闭合装置市场——增长、趋势和预测 (2023-2028)

Arteriotomy Closure Devices Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 114 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在预测期内，动脉切开术闭合装置市场的复合年增长率预计为 6.6%。

COVID-19 的爆发对市场产生了影响，因为在大流行期间血管疾病的比例显着增加。 例如，2022 年 3 月在 WebMD 上发表的一项研究发现，感染 COVID-19 的人感染后患 20 种心臟和血管疾病的风险增加。 它还说，长期 COVID-19 患者被诊断出 20 种心脏病。 专利闭合装置广泛用于减少血管并发症、止血和下床时间。 因此，血管疾病的增加增加了对动脉切开术闭合装置的需求，导致大流行期间市场显着增长。 COVID-19 疫情对市场产生了重大影响，但预计将在大流行后恢復强劲增长。

人口老龄化加剧是推动市场增长的主要因素。 例如，根据印度国家人口委员会2021年7月发布的报告，2021年印度约有1.38亿老年人，其中男性6700万，女性7100万，估计达数百万。 此外，老年人口的增长速度高于一般人口，据报导，过去20年老年人口增长了36.0%。 同样，2021 年 12 月发表的一项研究发现，在 45 岁及以上的人群中，自我报告的已确诊心血管疾病 (CVD) 总体患病率为 29.4%，患病率随年龄增长而增加。45-54 岁人群中为 22.0% 70岁及以上人群为38.0%，表明老年人患心血管疾病的风险较高，是发病率上升的主要因素。 因此，预计在预测期内将出现可观的市场增长。

但是，设备的高成本可能会阻碍预测期内的市场增长。

主要市场趋势

被动关闭装置预计在预测期内增长最快

被动闭合装置已成为介入心脏病专家和其他手术专业人员在导管插入部位实现止血的强大工具。 被动闭合装置通过机械压缩和增加血栓形成帮助实现有效止血。 然而，被动闭合装置不会加速止血所需的实际时间。 被动闭合装置通常是胶原蛋白（一种存在于皮肤、骨骼和结缔组织中的纤维蛋白）、金属夹或缝合线，旨在在血管造影后立即封闭动脉中的小穿孔。(Sucher)。

不断上升的高血压病例和人口老龄化是推动这一细分市场增长的主要因素。 例如，根据亚太卫生系统和政策观察站 2021 年 11 月发布的一份报告，到 2050 年，由于该地区的生育率下降和寿命延长，亚太地区约四分之一的人口将 1 60岁以上。 预计这将进一步增加心血管疾病的负担，并推动对有效和先进治疗方式的需求。 此外，根据澳大利亚健康与福利研究所 2022 的数据，估计 571,000 名 18 岁及以上的澳大利亚人（占成年人口的 2.9%）将在 2020 年至 2021 年期间患有心血管疾病。 这是基于澳大利亚统计局 2020-21 年全国健康调查的自我报告数据。 据说老年人更容易患心血管疾病和高血压。 因此，预计日益增加的老龄化人口将对该细分市场产生积极影响。

此外，高血压是导致心血管疾病的主要原因之一。 高血压被定义为 130 毫米汞柱或更高的收缩压或 80 毫米汞柱或更高的舒张压。 根据美国疾病预防控制中心 2021 年发布的一份报告，美国约有 47.0% 或超过一半的成年人患有高血压或正在服用降压药。 因此，预计老年人口的增加和心血管疾病负担的增加将在预测期内推动研究领域的增长。

预计北美地区在预测期内将显着增长

预计在预测期内，北美的整个动脉切开术闭合器械市场将出□□现显着增长。 这种增长是由于血管疾病病例增加和老年人口增加等因素造成的。 例如，根据美国疾病控制与预防中心2021年的数据，美国每年有超过805,000人心脏病发作，其中605,000人是第一次心脏病发作，200,000人有过心脏病发作史。 同样，美国心臟协会 2021 年杂誌估计，到 2035 年，美国将有超过 1.3 亿成年人患有某种形式的心脏病。 由于心血管疾病负担的增加，预计北美地区的市场将出现可观的增长。

主要产品的发布、市场参与者和製造商的高度集中、主要参与者之间的收购和合作以及美国心血管疾病的增加是推动该国动脉切开术闭合装置市场增长的一些因素。变成了一个部门。 例如，2021 年 9 月，Haemonetics Corporation 宣布 VASCADE MVP 静脉血管闭合系统获得 FDA 批准，用于治疗房颤 (AF) 消融术后当天出院的患者。

因此，上述因素有望推动北美地区研究市场的增长。

竞争格局

动脉切开术闭合装置市场竞争适中，由几家大型企业组成。 从市场份额的角度来看，目前几家大型企业占据了市场主导地位。 竞争格局包括拥有市场份额的知名国际参与者，如雅培实验室、Terumo Corporation、Cardinal Health (Cordis)、Cardiva Medical、Merit Medical、Medtronic PLC、Teleflex Incorporated、Vivasure Medical、OtsUnited Kingdoma Medical Devices (Veryan Medical)。包括对企业和一些本地企业的分析。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 血管疾病的发生率增加
    • 老年人口增加
  • 市场製约因素
    • 设备成本高
    • 与手术相关的风险
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分（基于价值的市场规模 - 百万美元）

  • 按产品分类
    • 主动关闭装置
    • 被动闭合装置
  • 通过申请
    • 股动脉通路手术
    • 桡动脉通路
  • 最终用户
    • 医院
    • 门诊中心
    • 其他最终用户
  • 按地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Abbott Laboratories
    • Cardinal Health（Cordis）
    • Cardiva Medical（Haemonetics）
    • Medtronic PLC
    • Merit Medical
    • Teleflex Incorporated
    • Terumo Corporation
    • OtsUnited Kingdoma Medical Devices Co. Ltd（Veryan Medical）
    • Vivasure Medical

第7章 市场机会与今后动向

简介目录
Product Code: 66775

The arteriotomy closure devices market is expected to register a CAGR of 6.6% over the forecast period.

The COVID-19 outbreak impacted the market as the rate of vascular diseases significantly increased during the pandemic. For instance, as per the study published in WebMD in March 2022, people who contracted COVID-19 were at a higher risk for 20 different heart and vascular diseases after being infected. The study also stated that 20 heart disorders were diagnosed in patients who suffered from long-term COVID-19 disease. Arteriotomy closure devices are widely used to decrease vascular complications and reduce the time to hemostasis and ambulation. Therefore, increasing cases of vascular diseases indicate that there was an increased demand for arteriotomy closure devices, owing to which the market witnessed considerable growth during the pandemic. Although the COVID-19 outbreak severely impacted the market, it is expected to recover in the post-pandemic era to post-strong growth.

The rising geriatric population is the major factor driving the market's growth. For instance, as per the report published by the National Commission on Population in India in July 2021, it was estimated that around 138.0 million elderly persons were living in India in 2021, of which 67.0 million were males, and 71.0 million were females. The report also stated that the growth rate of the elderly population was higher than that of the general population, and the elderly population has grown by 36.0% in the last two decades. Similarly, according to the research study published in December 2021, the overall self-reported prevalence of diagnosed cardiovascular diseases (CVDs) was 29.4% for older persons of age 45 and over, and the prevalence rate rose with age, from 22.0% in the 45-54 age group to 38.0% in the 70+ age group which shows that the geriatric population is at high risk of having cardiovascular diseases Thus, increasing geriatric population is one of the major factors for increasing the prevalence rate of cardiovascular diseases. Therefore, considerable market growth is anticipated over the forecast period.

However, the high cost of the devices may likely hinder the market's growth over the forecast period.

Key Market Trends

Passive Closure Devices Segment is Expected to Witness the Largest Growth over the Forecast Period

Passive closure devices have become a powerful tool for interventional cardiologists and other procedural professionals to achieve hemostasis at the catheter entry site. Passive closure devices help with mechanical compression or by increasing thrombosis for effective hemostasis. However, passive devices do not hasten the actual time it takes to reach hemostasis. The passive closure device is usually a piece of collagen (a fibrous protein found in skin, bone, and connective tissue), a metal clip, or a suture (suture) designed to provide immediate sealing of a small puncture made in an artery after an angiogram.

The increasing cases of hypertension and the rising geriatric population are the major factors propelling the segment's growth. For instance, as per the November 2021 report published by the Asian Pacific Observatory on Health Systems and Policies, by 2050, about one-fourth population of the Asia-Pacific region will be 60 years or older due to the decreasing fertility rate and increasing longevity in the region. This is further expected to increase the burden of cardiovascular diseases and thus drive the demand for effective and advanced treatment procedures. Furthermore, according to the Australian Institute of Health and Welfare in 2022, during 2020-2021, an estimated 571,000 Australians aged 18 and over (2.9% of the adult population) had cardiovascular diseases. This is based on self-reported data from the Australian Bureau of Statistics 2020-21 National Health Survey. The geriatric population is more prone to cardiovascular diseases and hypertension cases. Therefore, the rising geriatric population is expected to positively impact the segment.

Furthermore, hypertension is one of the major factors contributing to cardiovascular diseases. Hypertension is defined as systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg. According to the report published by CDC in 2021, around more than half of the adults in United States, which is around 47.0%, have hypertension or are taking medication for hypertension. Therefore, the increase in the geriatric population and the increasing burden of cardiovascular diseases is expected to fuel growth in the segment studied over the forecast period.

North American Region is Expected to Witness Significant Growth over the Forecast Period

North America is expected to witness significant growth in the overall arteriotomy closure devices market over the forecast period. The growth is due to factors such as the rising cases of vascular diseases and the increasing geriatric population. For instance, as per the 2021 data from the Centers for Disease Control and Prevention, every year, more than 805,000 people in United States have a heart attack; 605,000 of these result in a first-time heart attack, while 200,000 are caused by previous heart attacks. Similarly, as stated by the AHA 2021 Journal, it is estimated that by 2035, more than 130 million adults in United States will have some type of heart disease. With this increasing burden of cardiovascular diseases, the market is anticipated to witness considerable growth in the North American region.

Key product launches, high concentration of market players or manufacturers' presence, acquisitions, and partnerships among major players, and rising cardiovascular diseases in United States are some of the factors driving the growth of the arteriotomy closure devices market in the country. For instance, in September 2021, Haemonetics Corporation announced that the VASCADE MVP Venous Vascular Closure System had received FDA approval for treating patients having same-day discharge following atrial fibrillation (AF) ablation.

Therefore, owing to the aforementioned factors, the growth of the market studied is anticipated in the North American Region.

Competitive Landscape

The arteriotomy closure devices market is moderately competitive and consists of several major players. In terms of market share, a few of the major players currently dominate the market. The competitive landscape includes an analysis of a few international as well as local companies that hold the market shares and are well known, including Abbott Laboratories, Terumo Corporation, Cardinal Health (Cordis), Cardiva Medical, Merit Medical, Medtronic PLC, Teleflex Incorporated, Vivasure Medical, and Otsuka Medical Devices Co. Ltd (Veryan Medical), among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Incidences of Vascular Disorders
    • 4.2.2 Rising Geriatric Population
  • 4.3 Market Restraints
    • 4.3.1 High Cost of the Device
    • 4.3.2 Risk Associated With the Procedure
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Active Closure Devices
    • 5.1.2 Passive Closure Devices
  • 5.2 By Application
    • 5.2.1 Femoral Arterial Access Procedures
    • 5.2.2 Radial Arterial Access Procedures
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Ambulatory Care Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 Cardinal Health (Cordis)
    • 6.1.3 Cardiva Medical (Haemonetics)
    • 6.1.4 Medtronic PLC
    • 6.1.5 Merit Medical
    • 6.1.6 Teleflex Incorporated
    • 6.1.7 Terumo Corporation
    • 6.1.8 Otsuka Medical Devices Co. Ltd (Veryan Medical)
    • 6.1.9 Vivasure Medical

7 MARKET OPPORTUNITIES AND FUTURE TRENDS